Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Thyroid Neoplasms × Cetuximab × Clear all

Sponsor

Conditions

Colorectal Neoplasms 54 Head and Neck Neoplasms 51 Squamous Cell Carcinoma of Head and Neck 50 Carcinoma, Non-Small-Cell Lung 29 Rectal Neoplasms 21 Colonic Neoplasms 21 Carcinoma, Squamous Cell 16 Neoplasms 15 Neoplasm Metastasis 14 Lung Neoplasms 12 Pancreatic Neoplasms 11 Esophageal Neoplasms 11 Stomach Neoplasms 9 Recurrence 8 Tongue Neoplasms 7 Neoplasms, Squamous Cell 6 Mouth Neoplasms 6 Laryngeal Neoplasms 6 Carcinoma 6 Breast Neoplasms 6 Adenocarcinoma Of Esophagus 6 Parkinson Disease 4, Autosomal Dominant Lewy Body 5 Esophageal Squamous Cell Carcinoma 5 Adenocarcinoma of Lung 5 Oropharyngeal Neoplasms 4 Salivary Gland Neoplasms 3 Precancerous Conditions 3 Laryngeal Diseases 3 Hypopharyngeal Neoplasms 3 Carcinoma, Renal Cell 3

Interventions

vandetanib 7 lenvatinib 5 cabozantinib 4 Sunitinib 4 Sorafenib 4 AZD 6244 3 selpercatinib 2 durvalumab 2 alectinib 2 Triiodothyronine 2 Thyroxine 2 Paclitaxel 2 Iodine-131 2 Everolimus 2 Bortezomib 2 Axitinib 2 tremelimumab 1 tipifarnib 1 temsirolimus 1 tanespimycin 1 sapanisertib 1 regorafenib 1 pralsetinib 1 ponatinib 1 perflutren 1 pazopanib 1 pasireotide 1 methyl N-acetylsibirosaminide 1 gallium 68 PSMA-11 1 fosbretabulin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡